Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Bromocriptine, a dopamine receptor agonist initially approved in 1978 as Parlodel<SUP>&reg;</SUP>, has been approved for the treating type 2 diabetes mellitus. The drug is marketed as a quick release formulation by VeroScience LLC as Cycloset&trade;.

Bromocriptine Mesylate Tablets (Cycloset™)